Evacetrapib: in vitro and clinical disposition, metabolism, excretion, and assessment of drug interaction potential with strong CYP3A and CYP2C8 inhibitors

por Cannady, Ellen A, Wang, Ming-Dauh, Friedrich, Stuart, Rehmel, Jessica L F, Yi, Ping, Small, David S, Zhang, Wei, Suico, Jeffrey G
Publicado 2015